General Pathology Practice Questions

Q: The process by which differentiated cells can convert into a different cell type, acquiring the characteristics and functions of that new cell type, is referred to as:

Trans-differentiation. ***Trans-differentiation*** - **Trans-differentiation** is the process where a differentiated cell directly converts into another differentiated cell type without first undergoing a pluripotent state (like de-differentiation). - This process involves a complete change in the identity and function of the cell, acquiring features of a new, distinct cell type. *De-differentiation* - **De-differentiation** is the process by which a differentiated cell loses some or all of its specialized characteristics and returns to a more primitive or stem cell-like state. - This process is often a prerequisite for **regeneration** or can be observed in cancer cells, but it does not directly lead to a new differentiated cell type without further differentiation steps. *Re-differentiation* - **Re-differentiation** typically refers to the process where a de-differentiated cell (or a progenitor/stem cell) differentiates again into a specialized cell type. - It implies that the cell previously underwent de-differentiation and is now regaining its specialized functions, which is distinct from changing directly into a different cell type. *Cellular plasticity* - **Cellular plasticity** is a broad term describing the ability of cells to change their phenotype, state, or function in response to various cues. - While trans-differentiation is a form of cellular plasticity, it is a specific mechanism for direct cell conversion, whereas cellular plasticity encompasses a wider range of cellular adaptations including de-differentiation and reprogramming.

Q: Etiology of disordered coagulation in antiphospholipid syndrome is

Hyper coagulation. ***Hyper coagulation*** - Antiphospholipid Syndrome (APS) is characterized by the presence of **antiphospholipid antibodies** that promote a **prothrombotic state**, leading to both arterial and venous clotting. [1] - These antibodies interfere with regulatory proteins of coagulation (e.g., **protein C, protein S**) and interact with phospholipids on cell surfaces, causing increased platelet activation and endothelial dysfunction. *Slow blood flow* - While **venous stasis** can contribute to thrombosis, it is not the primary etiological factor for disordered coagulation in APS itself. - Slow blood flow is a component of **Virchow's triad**, which also includes endothelial injury and hypercoagulability, with the latter being the core issue in APS. [2] *Thrombocytosis* - **Thrombocytosis** (an abnormally high platelet count) can increase the risk of thrombosis, but it is not the direct or primary cause of disordered coagulation in APS. - APS specificially involves **antibody-mediated hypercoagulability**, not just an increased number of platelets. *Vitamin K malabsorption* - **Vitamin K malabsorption** can lead to a *deficiency* in vitamin K-dependent clotting factors, typically resulting in a **bleeding tendency** rather than hypercoagulation. - This condition is associated with **hypocoagulability**, which is the opposite of the disordered coagulation seen in APS.

Q: Which protein is primarily affected by mutations in Marfan's syndrome?

Fibrillin I. ***Fibrillin I*** - Marfan's syndrome is caused by a mutation in the **FBN1 gene**, which encodes the protein **fibrillin I**, crucial for connective tissue integrity [1]. - Clinical manifestations include **skeletal abnormalities**, **cardiovascular issues**, and **ocular problems**, linking the mutation to its phenotypic features [1]. *Collagen I* - While collagen is important for connective tissue, **collagen I** mutations are associated with disorders like **osteogenesis imperfecta**, not Marfan's syndrome. - This oes not account for the significant **fibrillin deficiency** noted in Marfan's patients. *Fibrillin II* - **Fibrillin II** does exist but is not the causative factor in Marfan's syndrome; mutations in this protein relate to different syndromes like **Congenital Contractural Arachnodactyly**. - The primary influence in Marfan's is due to the defect in **fibrillin I**, not fibrillin II. *Collagen IV* - Mutations in **collagen IV** are linked to diseases such as **Alport syndrome**, primarily affecting renal function and hearing, rather than the hallmark features of Marfan's. - This type of collagen is more critical for **basement membranes**, differentiating it from the connective tissue role of fibrillin I in Marfan's. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 35-36.

Q: Which is the central organelle in apoptosis?

Mitochondria. ***Mitochondria*** - Mitochondria play a crucial role in the intrinsic pathway of **apoptosis** by releasing cytochrome c and other pro-apoptotic factors [1]. - They are involved in the **regulation of cellular energy** and initiation of apoptotic signaling cascades, making them central to the process [1][2]. *Nucleus* - While the nucleus is involved in gene expression and can signal apoptosis, it is not the **central organ** where the apoptotic process primarily initiates. - The nucleus contains **DNA** that may undergo fragmentation during apoptosis, but it is the mitochondria that trigger these changes [1]. *Endoplasmic Reticulum* - The Endoplasmic Reticulum is essential for **protein synthesis** and can trigger apoptosis under stress (ER stress), but is not central in overall apoptosis regulation. - It influences **calcium homeostasis**, but the mitochondria have a more pivotal role in cell death mechanisms [1]. *Golgi body* - The Golgi body is primarily involved in the **modification and transport** of proteins, not in apoptosis. - Although it may indirectly affect cell function, it does not play a direct role in initiating or regulating the apoptotic process. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 64-65. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 65-67.

Q: In amyloidosis, beta pleated sheets can be directly visualized at the molecular level using:

X-ray crystallography. ***Congo red stain*** - Congo red stain is **specific** for detecting amyloid deposits, showing a characteristic **apple-green birefringence** under polarized light [1]. - The presence of **beta-pleated sheets** is a key feature of the amyloid fibrils that this stain highlights, confirming amyloidosis [1]. *Spiral electron microscope* - The **spiral electron microscope** is not a standard technique used for identifying amyloid structures or deposits. - It does not provide the **specificity** required to visualize amyloid-related beta-pleated sheets. *Electron microscope* - While electron microscopy can visualize amyloid fibrils [2], it does not specifically confirm the **beta-pleated sheet** structure like Congo red does. - This technique requires more complex preparations and does not have the same **ease of interpretation** for diagnosing amyloidosis. *X-ray crystallography* - X-ray crystallography is primarily used to determine the **three-dimensional** structure of crystalline substances, not specific to amyloid detection. - It does not provide direct evidence of **amyloid deposits** like Congo red staining does. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 268-269. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 135-136.

Q: Which enzymes are primarily responsible for the degeneration of the basement membrane?

Metalloproteinases. ***Metalloproteinases*** - **Matrix metalloproteinases (MMPs)** are a family of **zinc-dependent endopeptidases** that degrade various components of the **extracellular matrix (ECM)**, including the **basement membrane**. - Their activity is crucial in processes such as **tissue remodeling** and **wound healing**, and also in pathological conditions like **cancer invasion** and **metastasis** where basement membrane degradation is a key step. - **Type IV collagenase** (MMP-2 and MMP-9) specifically targets type IV collagen, the major structural component of basement membranes. *Oxidases* - Oxidases are enzymes that catalyze **oxidation-reduction reactions** involving molecular oxygen as the electron acceptor. - While they can indirectly contribute to tissue damage by generating **reactive oxygen species (ROS)**, their primary role is not the direct enzymatic degradation of the basement membrane. *Elastases* - Elastases are a type of **serine protease** that specifically break down **elastin**, a key component of elastic fibers in connective tissue. - While the basement membrane contains some proteins that might be affected, elastases are not the primary enzymes responsible for its general degradation. *Hydroxylases* - Hydroxylases are enzymes that catalyze the addition of a **hydroxyl group (-OH)** to a substrate. - They are involved in various metabolic pathways, including **collagen synthesis** (e.g., prolyl hydroxylase, lysyl hydroxylase), but they do not directly degrade the basement membrane.

Q: Liquefactive necrosis as a primary event is most often seen in:

CNS. ***CNS*** - **Liquefactive necrosis** primarily occurs in the **central nervous system** (CNS) due to the high lipid content of brain tissue and the rapid breakdown of neurons. - It often results from **ischemia** or severe **infections**, leading to the formation of a fluid-filled cystic area [1]. *Spleen* - The spleen typically undergoes **caseous necrosis** in conditions like tuberculosis, not liquefactive necrosis. - In infarcts, it often exhibits **coagulative necrosis**, where tissue architecture remains relatively intact. *Liver* - The liver primarily exhibits **coagulative necrosis** or **steatotic changes** due to various insults such as alcohol or viral hepatitis. - **Hemorrhagic necrosis** may occur in cases of fulminant hepatic failure but is still not liquefactive. *Kidneys* - Kidneys most commonly show **coagulative necrosis** during acute tubular injury rather than liquefactive necrosis. - In renal infarcts, the tissue remains firm, and necrotic areas do not undergo liquefaction as seen in the CNS. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1268-1269.

Q: Which of the following statements about apoptosis is not true?

Cellular swelling. ***Cellular swelling*** - **Apoptosis**, or programmed cell death, is characterized by cell shrinkage, not cellular swelling. - **Cellular swelling** is typically seen in **necrosis**, which is an uncontrolled form of cell death often due to injury. *Nuclear compaction* - **Nuclear compaction**, or **pyknosis**, is a hallmark feature of apoptosis where the nucleus condenses and fragments. - This process is crucial for the organized dismantling of the cell during programmed cell death. *Intact cell membrane* - In apoptosis, the **cell membrane** generally remains intact until the very late stages, preventing the release of cellular contents and subsequent inflammation. - This intactness differentiates apoptosis from necrosis, where the cell membrane ruptures early. *Formation of apoptotic bodies* - The cell fragments into small, membrane-bound structures called **apoptotic bodies**, which are then readily engulfed by phagocytes. - This mechanism allows for the efficient removal of dying cells without triggering an inflammatory response.

Question 1

The process by which differentiated cells can convert into a different cell type, acquiring the characteristics and functions of that new cell type, is referred to as:

Accepted Answer

Trans-differentiation

Answer

De-differentiation

Answer

Re-differentiation

Answer

Cellular plasticity

Question 2

Which of the following statements regarding cell aging is true?

Accepted Answer

Lipofuscin accumulates in cells with aging.

Answer

Free radicals cause cellular damage.

Answer

Mitochondrial content decreases with age.

Answer

Cell size typically decreases with aging.

Question 3

In which condition is caseating necrosis most characteristically observed?

Accepted Answer

Tuberculosis

Answer

Leprosy

Answer

Infarct

Answer

Sarcoidosis

Question 4

Etiology of disordered coagulation in antiphospholipid syndrome is

Accepted Answer

Hyper coagulation

Answer

Slow blood flow

Answer

Thrombocytosis

Answer

Vitamin K malabsorption

Question 5

Which protein is primarily affected by mutations in Marfan's syndrome?

Accepted Answer

Fibrillin I

Answer

Collagen I

Answer

Collagen IV

Answer

Fibrillin II

Question 6

Which is the central organelle in apoptosis?

Accepted Answer

Mitochondria

Answer

Nucleus

Answer

Endoplasmic Reticulum

Answer

Golgi body

Question 7

In amyloidosis, beta pleated sheets can be directly visualized at the molecular level using:

Accepted Answer

X-ray crystallography

Answer

Electron microscope

Answer

Congo red stain

Answer

Cryo-electron microscopy

Question 8

Which enzymes are primarily responsible for the degeneration of the basement membrane?

Accepted Answer

Metalloproteinases

Answer

Oxidases

Answer

Elastases

Answer

Hydroxylases

Question 9

Liquefactive necrosis as a primary event is most often seen in:

Accepted Answer

CNS

Answer

Kidneys

Answer

Spleen

Answer

Liver

Question 10

Which of the following statements about apoptosis is not true?

Accepted Answer

Cellular swelling

Answer

Nuclear compaction

Answer

Intact cell membrane

Answer

Formation of apoptotic bodies

General Pathology — MCQs

General Pathology — MCQs

On this page

Practice by Chapter

Want unlimited practice?